2025-03-31T16:36:05-05:00 2024-09-30 453564278 TMCE LLP 6425 YOUREE DR SHREVEPORT LA 71105 990 2023-10-01 721196625 OVERTON BROOKS RESEARCH CORPORATION MEDI OVER 3189905155 510 EAST STONER AVENUE SHREVEPORT LA 71101 JOHN T GLEASON EXECUTIVE DIRECTOR 3189905155 2025-03-31 1 0 ROBERT M EARNEST CPA P00067079 3182271600 2025-03-28 2023 2025-03-06 01:10:19Z JOHN T GLEASON 510 EAST STONER AVENUE SHREVEPORT LA 71101 358379 0 X X 1991 LA THE SOLE PURPOSE OF THE CORPORATION IS TO SUPPORT AND FACILITATE MEDICAL RESEARCH ACTIVITIES OF ITS MEMBERS IN CONJUNCTION WITH THE OVERTON BROOKS VETERANS AFFAIR MEDICAL CENTER. 6 2 6 4 0 0 0 0 264222 358311 36 68 0 0 264258 358379 0 0 0 0 166567 228387 0 0 0 31398 31439 197965 259826 66293 98553 122431 220984 0 0 122431 220984 X THE SOLE PURPOSE OF THE CORPORATION IS TO SUPPORT AND FACILITATE MEDICAL RESEARCH ACTIVITIES OF ITS MEMBERS IN CONJUNCTION WITH THE OVERTON BROOKS VETERANS AFFAIR MEDICAL CENTER. 1 0 242768 358311 NATIONAL INSTITUTES OF HEALTH (NIH) STUDY 2016-05 ALL OF US WITH DR. PHILIPS HADDAD AS PRINCIPAL INVESTIGATOR.(1) THE PROGRAM INVITES PEOPLE IN THE USA TO HELP BUILD DIVERSE HEALTH DATABASE. AT THIS VA, THE GOAL IS 40 ENROLLEES MONTHLY, A BLOOD DRAW IS REQUIRED. (2) THE GOAL IS TO ACCELERATE MEDICAL RESEARCH BREAKTHROUGHS BY DELIVERING ONE OF THE LARGEST BIOMEDICAL DATASETS TO RESEARCHERS WITH ONE MILLION OR MORE ENROLLED. (3) IT MAY TAKE YEARS TO UNDERSTAND HOW A VARIABLE IS LINKED TO A DISEASE OR TREATMENT, BUT BY CREATING A DATABASE OF THIS SIZE/SCOPE, NIH HOPES TO SPEED UP THIS PROCESS. 414 STUDY 1074: PROMINENT PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES. CSL BEHRING, LLC STUDY 1214 WITH DR. NEERAJ TANDON AS PRINCIPAL INVESTIGATOR(1) THIS PHARMACEUTICAL STUDY IS INVESTIGATING THE EFFICACY AND SAFETY OF A DRUG CALLED CSL 112. (2) GLOBALLY 10,584 PARTICIPANTS HAVE ENROLLED, BUT ONLY ONE FROM THISVAMC DUE TO THE TRICT INCLUSION/EXCLUSION CRITERIA. THE LONG-TERM GOAL IS TO REDUCE FUTURE CARDIOVASCULAR EVENTS IN PATIENTS WHO HAVE HAD A HEART ATTACK. (3) THE ONE VETERAN ENROLLED LOCALLY HAS HAD NO ADVERSE EVENTS AND IS BEING FOLLOWED PER PROTOCOL NOVARTIS PHARMACEUTICALS CORPORATION STUDY QI23-001 WITH DR. SANDRA BROWN AS PRINCIPAL INVESTIGATOR.(1) THIS STUDY CONTACTS VETERANS RECEIVING CARE AT OVERTON BROOKS VAMC CONCERNING THEIR CHOLESTEROL LEVELS. THER ARE OVER 37,000 VETERANS SERVES AT THIS FACILITY. (2) THE LONG-TERM GOAL IS TO IMPROVE THE CHOLESTEROL HEALTH THROUGH CONTACT WITH A HEALTH CARE COACH. (3) THIS IS A MULTI-SITE STUDY WITH NO FIXED STATISTICAL GOAL OTHER THAN TO APPLY EXISTING KNOWLEDGE TO DEVELOP INDIVIDUALIZED CARE SOLUTIONS TO LOWER CHOLESTEROL IN THE VETERAN POPULATION. THIS IS NOT RESEARCH REQUIRING INSTITUTIONAL REVIEW BOARD REVIEW. 243182 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 1 6 1 0 0 0 0 0 0 0 0 0 0 X 6 2 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 1 1 0 0 X DORTHY JARZABEK 3189905155 510 STONER AVE BLDG 33 SHREVPORT LA 711014295 PHILIP HADDAD MD DIRECTOR 5.00 X 0 0 0 PATRICK MCGAULY MD DIRECTOR 5.00 X 0 0 0 KAREN JOHNSON PHD DIRECTOR 5.00 X 0 0 0 JOHN T GLEASON LT COL RETIRED EXECUTIVE DIRECTOR 5.00 X 920 0 0 RICHARD L CROCKETT PRESIDENT 5.00 X 0 0 0 LAURA A HUFF TREASURER 5.00 X 0 0 0 920 0 0 0 0 0 0 0 RESEARCH REVENUE 621500 358311 358311 358311 68 68 358379 358379 0 0 920 920 211213 211213 16254 16254 6425 232 6193 1258 1258 1973 1973 NIH EXPENSES 15483 15483 CLINICAL CARD FILL 6300 6300 259826 243182 16644 0 122431 220984 122431 220984 0 0 X 0 0 0 0 122431 220984 122431 220984 122431 220984 98553 0 X 0 0 0 X OVERTON BROOKS VA HOSPITAL SHREVEPORT LA FORM 990, PART III, LINE 2 THE CORPORATION REGULARLY TAKES ON NEW RESEARCH PROJECTS THAT MIST BE APPROVED IN ACCORDANCE WITH PROCEDURES PRESCRIBED FOR FORMAL REVIEW BY THE VA MEDICAL CENTER RESEARCH AND DEVELOPMENT COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B, LINE 15A & SECTION C, LINE 19 THE BOARD OF DIRECTORS WILL BE GIVEN THE OPPORTUNITY TO REVIEW AND APPROVE THE ANNUAL IRS FORM 990 INFORMATION RETURN AT LEAST TWO WEEKS BEFORE THE FILING DATE. EXECUTIVE DIRECTOR: IS PAID A NOMINAL AMOUNT FOR REVIEWING DOCUMENTS/POLICIES/BUDGET, SIGNING CORRESPONDENCE, MANDATORY TRAINING, CONDUCTING MEETINGS AND APPROVING PURCHASE ORDERS AT A RATE OF PAY AT $40.00 PER HOUR. ALSO: PRINCIPAL INVESTIGATORS: FEDERAL LAW TITLE 18 USC 209(A) PROHIBITS A VA INVESTIGATOR FROM RECEIVING SALARY OR ANY CONTRIBUTION TO OR SUPPLEMENTATION OF SALARY FROM ANY SOURCE OTHER THAN THE UNITED STATES. BOARD MEMBERS: OBRC CURRENTLY DOES NOT PROVIDE ANY TYPE OF COMPENSATION FOR MEMBERS OF THE BOARD OF DIRECTORS. THERE IS NO COMPENSATION FOR TEAVEL EXPENSES TO ATTEND MEETING OF THE BOARD. THE ENTITY MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART III, LINE 2 AND 4D THE CORPORATION REGULARLY TAKES ON NEW RESEARCH PROJECTS THAT MIST BE APPROVED IN ACCORDANCE WITH PROCEDURES PRESCRIBED FOR FORMAL REVIEW BY THE VA MEDICAL CENTER RESEARCH AND DEVELOPMENT COMMITTEE. NOVARTIS PHARMACEUTICALS CORPORATION STUDY QI23-001 WITH DR. SANDRA BROWN AS PRINCIPAL INVESTIGATOR. (1) THIS STUDY CONTACTS VETERANS RECEIVING CARE AT OVERTON BROOKS VAMC CONCERNING THEIR CHOLESTEROL LEVELS. THER ARE OVER 37,000 VETERANS SERVES AT THIS FACILITY. (2) THE LONG-TERM GOAL IS TO IMPROVE THE CHOLESTEROL HEALTH THROUGH CONTACT WITH A HEALTH CARE COACH. (3) THIS IS A MULTI-SITE STUDY WITH NO FIXED STATISTICAL GOAL OTHER THAN TO APPLY EXISTING KNOWLEDGE TO DEVELOP INDIVIDUALIZED CARE SOLUTIONS TO LOWER CHOLESTEROL IN THE VETERAN POPULATION. THIS IS NOT RESEARCH REQUIRING INSTITUTIONAL REVIEW BOARD REVIEW. FORM 990, PART I, LINE 1 THE SOLE PURPOSE OF THE CORPORATION IS TO SUPPORT AND FACILITATE MEDICAL RESEARCH ACTIVITIES OF ITS MEMBERS IN CONJUNCTION WITH THE OVERTON BROOKS VETERANS AFFAIR MEDICAL CENTER. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS WILL BE GIVEN THE OPPORTUNITY TO REVIEW AND APPROVE THE ANNUAL IRS FORM 990 INFORMATION RETURN AT LEAST TWO WEEKS BEFORE THE FILING DATE. FORM 990, PART VI, SECTION B, LINE 15A EXECUTIVE DIRECTOR: IS PAID A NOMINAL AMOUNT FOR REVIEWING DOCUMENTS/POLICIES/BUDGET, SIGNING CORRESPONDENCE, MANDATORY TRAINING, CONDUCTING MEETINGS AND APPROVING PURCHASE ORDERS AT A RATE OF PAY AT $40.00 PER HOUR. ALSO: PRINCIPAL INVESTIGATORS: FEDERAL LAW TITLE 18 USC 209(A) PROHIBITS A VA INVESTIGATOR FROM RECEIVING SALARY OR ANY CONTRIBUTION TO OR SUPPLEMENTATION OF SALARY FROM ANY SOURCE OTHER THAN THE UNITED STATES. BOARD MEMBERS: OBRC CURRENTLY DOES NOT PROVIDE ANY TYPE OF COMPENSATION FOR MEMBERS OF THE BOARD OF DIRECTORS. THERE IS NO COMPENSATION FOR TEAVEL EXPENSES TO ATTEND MEETING OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ENTITY MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. OVERTON BROOKS MEDICAL CENTER 510 EAST STONER AVE SHREVEPORT LA 71101 720423660 VA HOSPITAL LA LINE 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0